| 1. |
- Lundström, Mats, et al.
(författare)
-
Validation of the Spanish Catquest-9SF in patients with a monofocal or trifocal intraocular lens
- 2016
-
Ingår i: Journal of Cataract and Refractive Surgery. - : Ovid Technologies (Wolters Kluwer Health). - 0886-3350. ; 42:12, s. 1791-1796
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose To validate the Spanish Catquest-9SF and study patient-reported visual function after implantation of a trifocal versus a monofocal intraocular lens (IOL). setting Clinica Baviera, Valencia and Madrid, Spain. Design Prospective case series. Methods The Catquest-9SF was translated from English to Spanish according to a standard procedure. The Spanish version was validated through Rasch analysis. Patients completed the Catquest-9SF before cataract surgery and 3 months after the surgery. The change in patient-reported visual function caused by surgery, the level of achieved visual function, and satisfaction with vision after surgery were assessed for bilaterally implanted trifocal IOLs versus monofocal IOLs. Results The Spanish Catquest-9SF showed very good psychometric properties. Patient-reported achieved visual function was significantly better for those with a trifocal IOL than for those with a monofocal IOL (P < .001). This was also true when the groups were matched for age and ocular comorbidity (P = .006). In multivariate analyses of all cases and matched cases (the same age and no comorbidity), the reported visual function was significantly better with trifocal IOLs than with monofocal IOLs (P = .001 and P = .008, respectively). There was greater improvement after trifocal IOL implantation in the matched cases, although not significant (P = .103). Conclusions Results show the Spanish version of Catquest-9SF is a valid patient questionnaire with good psychometric properties. Patients with a trifocal IOL implanted bilaterally reported better visual function than those with a monofocal IOL implanted bilaterally. The change in visual function after surgery was also greater in patients with a trifocal IOL. Financial Disclosure None of the authors has a financial or proprietary interest in any material or method mentioned.
|
|
